1. Forget Me Not: Closing the Gap After a Fragility Fracture
Kenneth W. Lyles, MD
Duke University and VA Medical Centers
Durham, NC 27710
May 4,2013

2. Conflict of Interest
Research Support: Novartis, Alliance for Better Bone Health, Amgen
Consultant: Novartis, Procter & Gamble, Merck, Amgen, Kirin Pharmaceutical, GTx, Eli Lilly, GSK, Bone Medical Ltd., Wyeth, Osteologix
Use Patent Co-Inventor: “Methods for preventing or reducing secondary fractures after hip fracture”, US Patent
Patent Inventor: “Medication Kits and Formulations for Preventing, Treating or Reducing Secondary Fractures After Previous Fracture”
Provisional Patent Application Co-Inventor “Bisphosphonates and Mortality Reduction”

3. Osteoporosis Management in Women Who Had a Fracture
Women over 67 years of age who suffered a fracture and then had a BMD measurement or prescription for a drug to treat or prevent osteoporosis in the six months after the fracture.
% %
% %
% %
% % %
5/1/2013